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Summary
 
Contact hypersensitivity (CHS) is a T cell–mediated skin inflammation induced by epicutane-
ous exposure to haptens in sensitized individuals. We have previously reported that CHS to
dinitrofluorobenzene in mice is mediated by major histocompatibility complex (MHC) class
I–restricted CD8
 
1
 
 T cells. In this study, we show that CD8
 
1
 
 T cells mediate the skin inflam-
mation through their cytotoxic activity. The contribution of specific cytotoxic T lymphocytes
(CTLs) to the CHS reaction was examined both in vivo
 
 
 
and in vitro,
 
 
 
using mice deficient in
perforin and/or Fas/Fas ligand (FasL) pathways involved in cytotoxicity. Mice double deficient
in perforin and FasL were able to develop hapten-specific CD8
 
1
 
 T cells in the lymphoid or-
gans but did not show CHS reaction. However, they did not generate hapten-specific CTLs,
demonstrating that the CHS reaction is dependent on cytotoxic activity. In contrast, Fas-defi-
cient 
 
lpr
 
 mice, FasL-deficient 
 
gld
 
 mice, and perforin-deficient mice developed a normal CHS
reaction and were able to generate hapten-specific CTLs, suggesting that CHS requires either
the Fas/FasL or the perforin pathway. This was confirmed by in vitro
 
 
 
studies showing that the
hapten-specific CTL activity was exclusively mediated by MHC class I–restricted CD8
 
1
 
 T cells
which could use either the perforin or the Fas/FasL pathway for their lytic activity. Thus, cyto-
toxic CD8
 
1
 
 T cells, commonly implicated in the host defence against tumors and viral infec-
tions, could also mediate harmful delayed-type hypersensitivity reactions.
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1
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C
 
ontact hypersensitivity (CHS)
 
1
 
 is a T cell–mediated
cutaneous inflammatory reaction occurring after epi-
cutaneous exposure to haptens in sensitized individuals (1–
3). In humans, it frequently manifests as an inflammatory
dermatosis referred to as contact dermatitis. Haptens are
low molecular weight chemicals which covalently bind to
discrete amino acid residues on self or exogenous proteins
(4). The sensitization phase, also referred to as the afferent
phase, occurs after the first contact of the skin with the
hapten. Hapten-modified proteins are loaded onto den-
dritic epidermal Langerhans cells (LCs) which migrate from
the epidermis to the regional draining LNs, where priming
of hapten-specific CD4
 
1
 
 and CD8
 
1
 
 T cells occurs (5, 6).
The elicitation phase, also known as the efferent phase, de-
velops within a few hours after subsequent contact with the
hapten, and is mediated by the activation of hapten-specific
T cells in the skin.
For many years, CHS was considered, like classical de-
layed-type hypersensitivity (DTH), to be mediated by
CD4
 
1
 
 T cells (7). Recent studies have demonstrated that
CHS to dinitrofluorobenzene (DNFB) was mediated by
IFN-
 
g
 
–producing CD8
 
1
 
 T cells only, whereas CD4
 
1
 
 T
cells downregulate this response (8–10). Thus, CHS can be
 
1
 
Abbreviations used in this paper:
 
 CHS, contact hypersensitivity; DNBS,
dinitrobenzene sulfonic acid; DNFB, dinitrofluorobenzene; DTH, de-
layed-type hypersensitivity; ELISPOT, enzyme-linked immunospot;
HPRT, hypoxanthine phosphoribosyltransferase; I
 
0/0
 
, MHC class I–defi-
cient; II
 
0/0
 
, MHC class II–deficient; P
 
0/0
 
, perforin-deficient; LC, Langer-
hans cell; SFC, spot-forming cell. 
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Contact Sensitivity Is Mediated by CD8
 
1
 
 CTLs
 
considered as an antigen-specific inflammation mediated by
hapten-specific CD8
 
1
 
 T cells, which differs from classical
DTH to protein antigens (1, 2). Although haptens are po-
tent inducers of CD8
 
1
 
 CTLs (11, 12), it is not known
whether CD8
 
1
 
 cells mediate the skin inflammation through
such cytotoxic activity or through the secretion of type 1
cytokines.
CD8
 
1
 
 CTLs are major effector cells of the immune de-
fence system against viruses and tumors (13) and exert their
lytic functions through two main independent mechanisms
(14–16). The secretory pathway involves the release of per-
forin and granzymes from cytolytic granules. The non-
secretory pathway involves interaction of the FasL upregu-
lated during T cell activation, with the apoptosis-inducing
Fas molecule on the target cell.
In this study, we investigated the contribution of CD8
 
1
 
T cell–mediated cytotoxicity to the pathophysiology of
CHS, using mice deficient in the Fas/FasL pathway (
 
lpr
 
and 
 
gld
 
 mice), the perforin pathway (perforin-deficient [P
 
0/0
 
]
mice), and in both cytolytic pathways (P
 
0/0
 
 
 
gld
 
 mice). The
results provide evidence that CD8
 
1
 
 T cells mediate CHS
through their cytolytic activity.
 
Materials and Methods
 
Mice.
 
C57BL/6 mice were purchased from IFFA Credo.
Mice homozygous for lpr mutation (
 
lpr
 
) and lacking the Fas
(CD95) molecule were obtained from Harlan. Mice homozygous
for perforin gene disruption (P
 
0/0
 
) completely lack perforin-
dependent cytotoxicity, while the Fas/FasL pathway remains fully
functional (17, 18). Mice homozygous for the gld mutation (
 
gld
 
),
homozygous for the gld mutation and heterozygous for the per-
forin deletion (P
 
1
 
/0
 
 
 
gld
 
), and mice double deficient for perforin
and carrying the gld mutation (P
 
0/0
 
 
 
gld
 
, unable to generate anti-
gen-specific CTLs [19]) were provided by Michael Hahne (Insti-
tute of Biochemistry, Lausanne, Switzerland). P
 
0/0
 
 
 
gld
 
 mice were
obtained by mating P
 
1
 
/0
 
 
 
gld
 
 mice, and the offspring were tested
for perforin deletion as described by Lowin et al. (18). Mice with
a mutation in the 
 
b
 
2 microglobulin gene (MHC class I–deficient
[I
 
0/0
 
]) or in the I-A
 
b
 
 gene (MHC class II–deficient [II
 
0/0
 
]) were
provided by Christophe Benoist and Diane Mathis (20, 21).
All mutant mice were on a C57BL/6 (H-2
 
b
 
) background
(backcrossed more than eight times with C57BL/6 mice) and
were used between 8 and 12 wk of age. 
 
Lpr
 
, 
 
gld
 
, and P
 
0/0
 
 
 
gld
 
mice, which develop a diffuse lymphoproliferation by the age of
2 mo, which could interfere with the development of the CHS
reaction, were used at the age of 6 wk, at a time when they show
no clinical sign of disease and have normal sized lymphoid organs.
P
 
0/0
 
, I
 
0/0
 
, and II
 
0/0
 
 mice were bred at the IFFA Credo/Transgenic
Alliance specific pathogen–free facility (L’Arbresle, France).
 
Chemicals.
 
DNFB and its water soluble form, dinitrobenzene
sulfonic acid (DNBS), were obtained from Sigma and used for in
vivo and in vitro experiments, respectively.
 
Antibody.
 
Ascites from the anti–MHC class I (heavy chain)
hybridoma 20.8.4.S was obtained from Jean-Pierre Abastado (In-
stitut Pasteur, Paris, France).
 
Assay for CHS to DNFB.
 
DNFB was diluted in acetone/ol-
ive oil (4:1) immediately before use. The procedure used for the
CHS, i.e., the mouse ear swelling test (MEST), has been de-
scribed elsewhere (22). In brief, 25 
 
m
 
l of 0.5% DNFB solution
 
was applied to a 2-cm
 
2
 
 area of shaved dorsal skin. After 5 d, test
and control animals received 10 
 
m
 
l of 0.15% (nonirritant concen-
tration) DNFB applied on both sides of the left ear, and the sol-
vent (acetone/olive oil) alone on the right ear. Ear thickness was
monitored using a micrometer (J15; Blet SA, France), before
challenge and every day after challenge. The ear swelling was cal-
culated as [(T 
 
2 
 
T
 
0
 
) left ear] 
 
2 
 
[(T 
 
2 
 
T
 
0
 
) right ear], where T and
T
 
0
 
 represent values of ear thickness after and before challenge, re-
spectively.
In each experimental group, some mice were killed at different
time intervals after DNFB challenge for histological and PCR
analysis.
 
RNA Extraction and Reverse Transcription PCR Analysis of CD8
and IFN-
 
g
 
 mRNA.
 
At different intervals after challenge, ear
samples were collected from sensitized or unsensitized mice and
frozen in liquid nitrogen. The detection of RNA was conducted
as described in detail elsewhere (23). In brief, total RNA was ex-
tracted using an RNAXEL kit (Eurobio). After DNase I treat-
ment, 1 
 
m
 
g of total mRNA was reverse transcribed using poly
dT15 primers and Superscript II RT (90 min, 37
 
8
 
C; GIBCO
BRL). The amount of RNA to be used for detection was nor-
malized using the housekeeping gene hypoxanthine phosphori-
bosyltransferase (HPRT) as reference. The cDNA obtained was
amplified using different sets of primers: for HPRT (5
 
9 
 
primer,
5
 
9
 
-GTA ATG ATC AGT CAA CGG GGG AC-3
 
9
 
; 3
 
9
 
 primer,
5
 
9
 
-CCA GCA AGC TTG CAA CCT TAA CCA-3
 
9
 
), for CD8
(5
 
9
 
 primer, 5
 
9
 
-AGG ATG CTC TTG GCT CTT CC-3
 
9
 
; 3
 
9
 
primer, 5
 
9
 
-TCA CAG GCG AAG TCC AAT CC-3
 
9
 
), and for
IFN-
 
g
 
 (5
 
9
 
 primer, 5
 
9
 
-GCT CTG AGA CAA TGA ACG CT-3
 
9
 
;
3
 
9
 
 primer, 5
 
9
 
-AAA GAG ATA ATC TGG CTC TGC-3
 
9
 
). The
amplifications were carried out with 29 cycles for HPRT and 33 cy-
cles for IFN-
 
g
 
 and CD8 (1 min at 94
 
8
 
C, 1 min 30 s at 60
 
8
 
C, 2 min
at 72
 
8
 
C). The PCR products were analyzed on 1.5% agarose gel.
 
In Vitro Secondary T Cell Proliferation.
 
Spleen cells from DNFB-
sensitized C57BL/6 and P
 
0/0
 
 gld mice were collected 5 d after
sensitization. T lymphocytes were purified through negative se-
lection using anti-Ig columns (Biotex) as described elsewhere (6).
The resulting cell suspensions contained .90% CD31 viable
cells. CD81 T cells were isolated from the spleen T cells by elim-
ination of CD41 T cells using columns coated with goat anti–
mouse and goat anti–rat IgG and a rat anti–mouse CD41 mAb
(YTS191.1; Biotex). FACS® analysis of cells eluted from the
column showed ,0.5% contaminating CD41 T cells. In vivo
DNFB-primed unfractionated or CD81 T cells (2.5 3 105/well)
obtained on day 5 after DNFB sensitization were cocultured for 3 d
at 378C in 96-well plates with 106 mitomycin C–treated syngenic
spleen cells from naive mice, that were either DNBS-derivatized
as described (6) or left untreated. In brief, 107 cells were incu-
bated for 30 min with 25 mg/ml of mitomycin C (Sigma),
washed, and haptenated by 30-min incubation at 378C with 4
mM DNBS, pH 8.0, in serum-free RPMI medium. The prolifer-
ative responses were assessed on day 3 of culture by [3H]thymi-
dine incorporation (1 mCi/well) for the last 6 h of culture. The
results are expressed as proliferation indices: (cpm in cultured T
cells 1 DNBS-treated spleen cells)/(cpm in cultured T cells 1
untreated spleen cells).
IFN-g Enzyme-linked Immunospot Assay. Inguinal and axil-
lary LNs were harvested 5 d after DNFB sensitization. Cell sus-
pensions were restimulated in vitro  by overnight culture in
complete RPMI medium supplemented with 10% FCS and con-
taining a final concentration of 0.4 mM DNBS. Control cultures
included cells cultured overnight in medium supplemented with
0.2 mM of the irrelevant hapten TNBS, or in medium alone.781 Kehren et al.
The number of IFN-g–producing cells was determined using an
enzyme-linked immunospot (ELISPOT) assay. In brief, 96-well
nitrocellulose plates (MAHA 45; Millipore) were coated over-
night at 48C with anti–IFN-g antibody (R46A2) and blocked
with PBS/2% BSA for 2 h at 378C. The plates were washed three
times with PBS/Tween 0.1% before use. The cell suspensions
were washed, and incubated at different concentrations in dupli-
cate wells for 4 h at 378C, 5% CO2. Plates were washed three
times with PBS/0.1% Tween and incubated with a biotinylated
anti–IFN-g antibody (AN18). IFN-g spot-forming cells (SFCs)
were developed using streptavidin–alkaline phosphatase (Boeh-
ringer Mannheim), incubated for 2 h, and extensively washed be-
fore adding the substrate (5-bromo-4-chloro-3-indolyl-phos-
phate; Sigma). The number of IFN-g SFCs present in each well
was counted using a microscope, and the results were expressed
as IFN-g SFCs/106 cells.
Production of CTLs. DNBS-specific CTLs were recovered
from splenocytes of various H-2b mice. Spleens were recovered 5 d
after cutaneous sensitization with DNFB, perfused with RPMI to
eliminate red blood cells. 107 splenocytes were used either fresh
or after restimulation for 5 d in culture with 107 syngenic mito-
mycin C–treated, DNBS-derivatized spleen cells from either nor-
mal C57BL/6, I0/0, or II0/0 mice.
Target Cells. Target cells included MBL2 and MBL2-Fas cell
lines, provided by Maries van den Broeck (Institute of Experi-
mental Immunology, University of Zurich, Zurich, Switzerland
[24]), and EL-4 cells, all maintained in RPMI plus 10% FBS.
Target cells were simultaneously haptenated and labeled by incu-
bating 2 3 106 cells in 10 ml of RPMI with or without 40 mM
DNBS and 100 mCi of Na2
51CrO4 (sodium chromate solution, 1
Ci/mM) for 1 h at 378C with periodic mixing. Labeled targets
were washed thoroughly before use.
Cytotoxicity Assays. Various numbers of effector cells were
incubated at 378C for 4 h with 104 labeled target cells. Superna-
tants were then collected, and 51Cr release was counted in a g
counter. The percentage of cytotoxicity was calculated using the
formula: 100 3 (experimental cpm 2 spontaneous cpm)/(maxi-
mal cpm 2 spontaneous cpm), where the maximal cpm and
spontaneous cpm are the radioactivity released from targets ex-
posed to 0.5 M HCl or medium, respectively. The results pre-
sented are representative of at least three independent experi-
ments.
Statistical Analysis. Data were examined for normality and
equal variance, and groups were compared by a two-tailed Stu-
dent’s t test.
Results
CHS Reaction to DNFB Is Impaired in Perforin and FasL
Double-knockout (P0/0 Gld) Mice. The contribution of CD81
T cell–mediated cytotoxicity to the CHS reaction to
DNFB was examined in mice double deficient for Fas/FasL
and perforin (P0/0 gld), which are devoid of CTL activity
(15). The CHS reaction was dramatically reduced in P0/0
gld mice compared with that observed in C57BL/6 mice
(Fig. 1 a). No difference in ear swelling could be observed
between the sensitized and unsensitized groups of P0/0 gld
mice and the unsensitized C57BL/6 mice. Similarly, none
of the characteristic pathological changes occurring during
a normal CHS reaction, namely edema, vascular enlarge-
ment, and mononuclear cell infiltration, was observed in
P0/0 gld mice (Fig. 1 b).
Spleen cells from sensitized animals were tested for their
ability to lyse haptenated targets either directly or after in
vitro  restimulation. As shown in Fig. 1 c, T cells from
DNFB-sensitized C57BL/6 mice exhibited a potent hap-
ten-specific CTL activity after restimulation in vitro but
which was already detectable directly ex vivo (data not
shown). In contrast, DNFB-specific CTLs could never be
Figure 1. CHS to DNFB is impaired in P0/0 gld mice. (a) CHS to DNFB was analyzed in groups of four wild-type C57BL/6 (squares) or P0/0 gld (cir-
cles) mice either sensitized with DNFB (filled symbols) or unsensitized (open symbols) and challenged 5 d later on the left ear. Results are expressed as
the mean ear swelling (in mm) at different time points after challenge. Results are representative of three independent experiments. (b) Histological anal-
ysis of the CHS reaction 24 h after challenge in C57BL/6 and P0/0 gld mice. Major changes were observed in C57BL/6 mice, including edema of the der-
mis, mononuclear cell infiltration, and enlargement of blood vessels. No main histological modification was noted in the skin of P0/0 gld mice. Original
magnification: 3100. (c) Cytotoxic activity of spleen cells from DNFB-sensitized C57BL/6 mice (j), P0/0 gld mice (d), or naive C57BL/6 mice (h)
was assessed after in vitro restimulation for 5 d with haptenated C57BL/6 mice spleen cells. Specific cytotoxic activity was determined by hapten-pulsed
MBL2-Fas target lysis in a 4-h 51Cr-release assay. Results are representative of three independent experiments.782 Contact Sensitivity Is Mediated by CD81 CTLs
demonstrated in double-deficient P0/0 gld mice ex vivo, nor
after in vitro restimulation with DNBS-derivatized cells.
Thus, P0/0 gld mice cannot produce a CHS reaction to
DNFB and are unable to develop any of the pathological
changes associated with CHS, suggesting that hapten-spe-
cific CTL activity is mandatory for expression of the CHS
reaction.
DNFB Can Prime for Specific CD81 T Cells in the Lym-
phoid Organs of Perforin and FasL Double-deficient Mice. To
determine whether the lack of CHS reaction in P0/0 gld
mice is secondary to an impairment in the priming of spe-
cific CD81 T cells in the lymphoid organs, P0/0 gld and
C57BL/6 mice were sensitized with DNFB, and lymphoid
cells were recovered 5 d later and tested for hapten-specific
proliferative responses and IFN-g production.
Lymphocytes from P0/0 gld mice responded vigorously to
hapten-treated syngenic cells in secondary proliferative re-
sponses, with stimulation indices identical to those ob-
served with T cells recovered from sensitized C57BL/6
mice (Fig. 2 a). Similarly, CD81 T cells from P0/0 gld mice
exhibited hapten-specific responses indistinguishable from
those of control C57BL/6 cells. Thus, CD81 T cell prim-
ing has occurred in the lymphoid organs of P0/0 gld mice.
We next used an ELISPOT assay to determine the fre-
quency of DNFB-specific, IFN-g–producing LN cells in
primed C57BL/6 and P0/0 gld mice. In C57BL/6 mice, the
IFN-g–producing cells were entirely contained in the
CD81 T cell subset, with a mean frequency of 3 IFN-g
SFCs/105 LN cells (Fig. 2 b). Interestingly, P0/0 gld mice
exhibited comparable levels of hapten-specific, IFN-g–pro-
ducing cells (Fig. 2 c).
These data indicate that the lack of CHS in double-defi-
cient P0/0 gld mice is not due to impaired priming of hap-
ten-specific CD81 T cells nor to an altered production of
IFN-g, but rather to the deficient CTL activity.
IFN-g–producing CD81 T Cells of P0/0 Gld Mice Migrate to
the Challenged Skin but Are Unable to Induce the Recruitment of
Inflammatory Cells. Two possibilities could explain why
P0/0 gld mice did not show a CHS response despite the
presence of IFN-g–producing DNFB-specific CD81 T
cells in the lymphoid organs: (a) primed CD81 T cells lack-
ing cytolytic activity are unable to migrate from the blood
to the skin; (b) CD81 T cells are able to infiltrate the skin
but, due to lack of cytolytic functions, are unable to induce
recruitment of inflammatory cells mandatory for the full
development of CHS. Since the CHS reaction to DNFB is
associated with the infiltration of IFN-g–producing CD81
T cells in situ a few hours after challenge (Akiba, H.,
manuscript in preparation), we examined the presence of
CD81 T cells and the expression of IFN-g in the skin of
P0/0 gld and C57BL/6 mice after sensitization and challenge
(Fig. 3). PCR analysis demonstrated that CD8 and IFN-g
mRNAs were not found in the skin of naive mice or in
hapten-painted ears of unsensitized mice. In contrast, up-
regulation of both CD8 and IFN-g mRNA occurred as
early as 6 h after challenge in both C57BL/6 and P0/0 gld
mice, indicating that lack of both perforin and FasL did not
affect the migration of CD81 T cells to the skin. However,
at 24 and 48 h after challenge, dramatic differences were
noted. C57BL/6 mice showed a gradual increase in the in-
tensity of the CD8 and IFN-g mRNA expression, whereas
no signal was observed in the skin of P0/0 gld mice. These
results suggest that DNFB-specific CD81 T cells from P0/0
gld mice are able to migrate from blood to skin, but cannot
induce the specific signals necessary for the constitution of
the inflammatory cellular infiltrate.
DNFB-specific CHS and CTL Responses Develop in Lpr
Mice, Gld Mice, and P0/0 Mice. To determine the relative
contribution of the Fas/FasL and perforin pathways to the
CHS response, we tested the ability of Fas-deficient (lpr),
Figure 2. Hapten-specific T
cell responses in P0/0  gld mice.
(a) Secondary proliferative re-
sponses. T cells and CD81 T
cells were purified from the
spleen and LNs of DNFB-sensi-
tized C57BL/6 and P0/0 gld mice
and tested for proliferative re-
sponses to hapten-modified or
unmodified syngenic spleen cells
in a 6-h [3H]thymidine assay on
day 3 of culture. Results are ex-
pressed as stimulation indices:
([3H] cpm incorporation of T
or CD81 cells cultured with
DNBS-modified spleen cells/
[3H] cpm incorporation of T or
CD81 cells cultured with non-
modified spleen cells). Coculture
with nonmodified spleen cells determines the level of nonspecific proliferation: TC57BL/6 5 894 (678) cpm; CD81
C57BL/6 5 672 (6266) cpm; TP0/0 gld 5
936 (6300) cpm; CD81
P0/0 gld 5 775 (6256) cpm. Results are representative of three independent experiments. (b) Hapten-specific IFN-g–producing
cells were determined by ELISPOT assay in LN cells from DNFB-sensitized C57BL/6 mice, after overnight restimulation with DNBS (j), TNBS (s),
or medium alone. In some experiments, CD8 depletion of DNBS-restimulated LN cells was performed before the ELISPOT assay (h). No spots were
detected in unsensitized mice after in vitro culture with or without haptens (not shown). (c) DNBS-specific IFN-g SFCs in LNs from C57BL/6 mice
and P0/0 gld mice after overnight restimulation with (black bars) or without (white bars) DNBS.783 Kehren et al.
FasL-deficient (gld), and P0/0 mice to exhibit specific CHS
and CTL responses after DNFB sensitization.
In marked contrast to double-deficient P0/0 gld mice, lpr,
gld, or P0/0 mice developed a normal CHS reaction to
DNFB (Fig. 4 a), with intensity, kinetics, and histological
characteristics comparable to those observed in C57BL/6
mice. Mice homozygous for the gld mutation and het-
erozygous for the perforin deletion (P1/0 gld) also had a
similar reaction to DNFB (data not shown). Interestingly,
lpr, gld, and P0/0 mice exhibited a strong hapten-specific
CTL response (Fig. 4 b) as well as normal quantities of
DNFB-specific, IFN-g–producing LN cells (data not shown).
Thus, exclusion of only one cytolytic pathway did not
prevent the induction of hapten-specific CTLs nor the de-
velopment of a CHS reaction to DNFB, indicating that
CTLs can use either the Fas/FasL or the perforin pathway
to mediate CHS.
Hapten-specific CTL Activity Is Found in the MHC Class
I–restricted CD81 T Cell Subset and Is Mediated by Both Per-
forin and Fas/FasL. The above data demonstrating that
CTLs mediate the CHS reaction to DNFB were obtained
in mice genetically deficient for molecules involved in
CTL activity, raising the question of the nature of the cells
endowed with the specific CTL activity and of the exist-
ence of similar mechanisms in normal C57BL/6 mice,
which have both functional perforin and Fas/FasL path-
ways.
Hapten-specific CTL activity was restricted to the MHC
class I–restricted CD81 T cell subset. Indeed, depletion of
CD81 cells, but not of CD41 cells, totally abolished the
CTL activity of primed C57BL/6 spleen cells (data not
shown). MHC class I molecules were mandatory for the
induction, expansion, and effector function of specific
CD81 CTLs, since: (a) primed spleen cells from C57BL/6
and II0/0, but not from I0/0, mice could lyse haptenated tar-
gets (Fig. 5 a); (b) hapten-specific lysis was not observed
when effector cells were restimulated in vitro with hapten-
ated APCs from I0/0 mice (Fig. 5 b); and (c) CTL activity of
C57BL/6 spleen cells was suppressed by incubation with
mAbs to the Kb MHC class I molecules (Fig. 5 c). These
results indicate that the hapten-specific CTLs are “classical”
MHC class I–restricted CD81 T cells.
The contribution of perforin or Fas/FasL to the CTL ac-
tivity was tested using perforin1 (from C57BL/6 mice) and
perforin-deficient (from P0/0 mice) effectors and targets
comprising Fas1 (MBL2-Fas) and Fas-deficient (MBL2)
Figure 3. Detection of CD8 and IFN-g mRNA during the elicitation
phase of the CHS. (a) CD8 and IFN-g mRNA expression in situ was an-
alyzed using semiquantitative RT-PCR: mRNA was obtained from the
ears of mice at 6, 24, and 48 h after challenge. Controls include ears of
untreated mice (naive) and ears of nonsensitized but challenged mice (un-
sensitized). (b) Histogram representation of the CD8 and IFN-g mRNA
relative quantities compared with HPRT mRNA as standard. Each band
was analyzed by densitometry, and the results are expressed as ratios of
optical densities to HPRT band. Results are representative of two in-
dependent experiments.
Figure 4. Normal CHS reaction of prim-
ing of specific CTLs in Fas-deficient (lpr),
FasL-deficient (gld), and P0/0 mice. (a)
Groups of five gld (squares), lpr (triangles),
and P0/0 (circles) mice were sensitized with
DNFB (filled symbols) or left unsensitized
(open symbols), and challenged 5 d later on
the left ear. Results are expressed as the
mean ear swelling (in mm) at different time
points after challenge. (b) Spleen cells from
DNFB-sensitized  gld (squares), lpr (trian-
gles), and P0/0 (circles) mice were restimu-
lated in vitro for 5 d with syngenic hapte-
nated spleen cells. Specific cytotoxic activity
was determined by hapten-pulsed MBL2-
Fas target lysis in a 4-h 51Cr-release assay.
Results are representative of three indepen-
dent experiments.784 Contact Sensitivity Is Mediated by CD81 CTLs
cells. As shown in Fig. 5 d, perforin-deficient effectors
could lyse hapten-treated Fas1 cells, but not Fas-deficient
cells, whereas perforin1 CTLs were able to lyse Fas-defi-
cient cells as efficiently as Fas-expressing cells. Thus, hap-
ten-specific MHC class I–restricted CD81 CTLs could use
the Fas/FasL or the perforin pathway for their CTL activ-
ity, which could be abolished only by inactivation of both
cytolytic pathways.
Discussion
This study demonstrates that CD81 T cells require cyto-
toxic activity to mediate CHS. The invalidation of the two
main cytolytic pathways, as observed in mice deficient in
perforin and FasL (P0/0 gld), is responsible for the lack of
generation of specific CTLs and for the abolition of the
CHS reaction. Interestingly, the presence of a single cy-
tolytic pathway, in lpr mice, gld mice, and P0/0 mice, is suffi-
cient for the development of a CHS reaction and for the
priming of specific CTLs, indicating that the Fas/FasL and
the perforin pathways could be used independently and
with similar efficiency for cytolytic activity. These results
are in line with recent data on influenza virus infection
showing that virus clearance by CTLs could be achieved
only if one of the two main lytic pathways remained func-
tional (25).
Until our study, cytokines, and especially IFN-g and
TNF-a, were thought to mediate skin inflammation through
their ability to activate keratinocytes and endothelial cells
(2, 26–29). Recent studies excluded a pivotal role for IFN-g
in the elicitation phase of CHS, since IFN-g receptor–defi-
cient mice developed a normal CHS reaction (30). In addi-
tion, studies in TNF-a–deficient mice indicated that the
cytokine was not involved in the elicitation phase but
played an important role in the sensitization phase by in-
ducing the emigration of LCs to the draining LNs (29).
CHS develops in two phases, the sensitization (i.e., affer-
ent) phase leading to the priming of hapten-specific CD81
T cells and the elicitation (i.e., efferent) phase occurring af-
ter challenge and leading to the development of skin in-
flammation. MHC class I molecules expressed by LCs are
mandatory for the priming of hapten-specific CD81 T cells
in the LNs during the afferent phase (6, 31). These MHC
class I–restricted CD81 T cells exert CHS through CTL
activity using classical cytolytic pathways. That cytotoxicity
is the effector mechanism responsible for the efferent phase
of CHS is supported by the observation that hapten-
primed, IFN-g–producing CD81 T cells are present in
lymphoid organs of P0/0 gld mice and respond vigorously in
secondary proliferative responses, demonstrating that the
lack of CHS reaction is not due to an impairment of the
sensitization phase of CHS, but rather reflects an alteration
during the elicitation phase.
The mechanisms involved in the development of skin
inflammation upon challenge in sensitized mice, i.e., dur-
ing the elicitation phase, associates hapten-specific and
nonspecific steps (2). First, lymphocytes have to emigrate
from the blood to the skin. Infiltration of the skin by
mononuclear cells has been reported to occur within a few
hours after challenge (32). Haptens are able to directly in-
duce expression of E- and P-selectins on endothelial cells 2 h
after skin painting (33, 34). It is thought that circulating
antigen-specific memory T cells which carry homing re-
ceptors (the cutaneous leukocyte-associated antigen [CLA]
molecule) are able to enter the skin (35) through interac-
tion with P- and E-selectins expressed on endothelial cells
(36). Second, specific T cells are activated on hapten pre-
sentation by skin-resident cells, as revealed by detection of
IFN-g mRNA in situ between 4 and 8 h after challenge
(37, 38). Third, activation of skin-resident cells by T cell
cytokines results in the amplification of the inflammatory
reaction leading to the cellular inflammatory infiltrate.
Upon IFN-g activation, keratinocytes upregulate intercel-
lular adhesion molecule 1 (ICAM-1) and Ia molecules
and produce a wide array of inflammatory cytokines and
chemokines such as IL-8 (2, 26, 39, 40). Likewise, endo-
Figure 5. MHC class I molecules are mandatory for the generation (a),
expansion (b), and effector functions (c) of specific CTLs, which can lyse
their targets through Fas/FasL- or perforin-mediated mechanisms (d).
Specific cytotoxic activity was determined by lysis of hapten-pulsed EL-4
targets (a, b, and c) or MBL2 and MBL2-Fas targets (d) in a 4-h 51Cr-
release assay. (a) Spleen cells from DNFB-sensitized C57BL/6 (squares), II0/0
(circles), and I0/0 mice (triangles) were restimulated in vitro for 5 d with
haptenated C57BL/6 mice spleen cells. (b) Spleen cells from DNFB-sen-
sitized C57BL/6 mice were restimulated in vitro for 5 d with haptenated
spleen cells from naive C57BL/6 (squares), II0/0 (circles), or I0/0 mice (tri-
angles). (c) Cytotoxic activity of C57BL/6 mice spleen cells against hap-
tenated EL-4 cells (j) was inhibited by addition of the 20.8.4.S mAb to
the Kb MHC class I molecules (s). Antibody was used at 1:500 (solid
line) and 1:100 (hatched line). (d) Spleen cells from sensitized C57BL/6
mice (squares) and P0/0 mice (circles) were restimulated in vitro for 5 d
with syngenic haptenated spleen cells and tested for cytotoxic activity
against hapten-pulsed Fas1 (MBL2-Fas; filled symbols) or Fas2 (MBL2;
open symbols) targets. Results are representative of three to four indepen-
dent experiments.785 Kehren et al.
thelial cell activation is followed by leukocyte migration
from the blood vessels to the dermis, leading to the forma-
tion of inflammatory cellular infiltrate (2, 26). In this
scheme, the hapten-specific limb of the CHS reaction cor-
responds to the activation of hapten-specific T cells and oc-
curs z6 h after challenge, whereas the nonspecific phase
corresponds to the infiltration of the skin by the polymor-
phic cellular infiltrate, which peaks 24 h after challenge.
It appears from our data that the failure of P0/0 gld mice
to exhibit a CHS reaction is not due to the inability of
CD81 T cells to infiltrate the skin or to be activated, since
IFN-g–producing CD81 T cells could be detected in the
skin 6 h after challenge, at levels comparable to those found
in C57BL/6 mice. However, these early parameters of the
CHS reaction were not followed by an increase in cellular
infiltration in situ, as observed in C57BL/6 mice at 24 and
48 h. These observations suggest that cytolytic function of
hapten-specific CD81 T cells is required for the recruit-
ment of inflammatory cells and full development of the
CHS response. Both epidermal dendritic LCs and kerati-
nocytes express MHC class I molecules and may produce
upon activation (or lethal hit) a wide array of inflammatory
cytokines and chemokines. Destruction of haptenated LCs
by CTLs may account for the recent observation that LCs
undergo apoptotic cell death in CHS (41). Alternatively,
keratinocytes, which represent .90% of epidermal cells,
could be the targets of antihapten CTLs, the more so since
IFN-g, produced in situ during the course of CHS, upreg-
ulates Fas expression by keratinocytes (42).
In conclusion, our data demonstrate that CHS to DNFB
is mediated by hapten-specific CTLs which may use either
the Fas/FasL or the perforin pathway for the induction of
cutaneous inflammation. The precise nature of the MHC
class I–expressing skin cells able to present the hapten to
CTLs in vivo during the elicitation phase is currently under
investigation.
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